Euroespes, S.A. (BME: EEP)
Health Care · Life Sciences Tools & Services · ES
€—
— today · — 1Y
Euroespes, S.A. (BME: EEP) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $4.29M and employs 39 people.
trading between 0.32 and 0.52.
Tweenvest scores Euroespes, S.A. across four factors: quality 54/100, growth 0/100. Its strongest factor is quality.
EEP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.29M
- Revenue (TTM)
- $3.66M
- P/E
- —
- EPS
- 0.00
- Dividend yield
- —
- Beta (5Y)
- -0.16
- 52-week high
- €0.52
- 52-week low
- €0.32
- Avg volume (3M)
- —
- Shares outstanding
- 11.61M
- Employees
- 39
- Next earnings
- —
About Euroespes, S.A.
Euroespes, S.A. functions as a healthcare institution, offering a range of medical services both domestically in Spain and internationally. Its primary mission involves the investigation, identification, and therapeutic management of central nervous system disorders, as well as various other ailments. The company specializes in personalized and genomic medicine, applied for predictive insights, accurate diagnosis, and effective treatment. Additionally, it provides specific medical disciplines such as neuro-ophthalmology, neuro-otorhinolaryngology, neuropsychology, advanced digital diagnostics, radiodiagnosis, comprehensive clinical laboratory analysis, nursing care, and cardiology services. Beyond its clinical offerings, Euroespes is dedicated to research and development across fields including biochemistry, health biotechnology, epigenetics, pharmacogenomics, and nutraceuticals. The entity was founded in 1991 and maintains its headquarters in Corunna, Spain.
- ISIN
- ES0133421000
- Founded
- 1991
- Listed since
- Feb 16, 2011
- Exchange
- Bolsas y Mercados Espanoles
- Currency
- EUR
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $234.31B | $635.39 | +0.27% |
| Danaher CorporationNYSE: DHR | $151.40B | $217.83 | +1.15% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $70.42B | CN¥159.25 | -1.09% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $50.96B | CHF584.80 | -0.51% |
| Agilent Technologies, Inc.NYSE: A | $43.80B | $157.79 | +1.75% |
| IQVIA Holdings Inc.NYSE: IQV | $43.04B | $263.54 | +0.78% |
| Waters CorporationNYSE: WAT | $40.69B | $423.68 | +2.30% |
Figures last refreshed Aug 18, 2026.